146 related articles for article (PubMed ID: 25546479)
1. A comparison of intravitreal bevacizumab and steroid activity in an experimental uveitis model.
Ayyıldız O; Durukan AH; Ozgurtas T; Gunal A
Curr Eye Res; 2015; 40(12):1261-8. PubMed ID: 25546479
[TBL] [Abstract][Full Text] [Related]
2. Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy.
Arimura N; Otsuka H; Yamakiri K; Sonoda Y; Nakao S; Noda Y; Hashiguchi T; Maruyama I; Sakamoto T
Ophthalmology; 2009 May; 116(5):921-6. PubMed ID: 19410951
[TBL] [Abstract][Full Text] [Related]
3. The effect of triamcinolone acetonide or bevacizumab on the levels of proinflammatory cytokines after retinal laser photocoagulation in pigmented rabbits.
Arimura S; Takamura Y; Miyake S; Gozawa M; Iwasaki K; Tomomatsu T; Matsumura T; Inatani M
Exp Eye Res; 2016 Aug; 149():1-7. PubMed ID: 27296072
[TBL] [Abstract][Full Text] [Related]
4. Aqueous humor levels of vascular endothelial growth factor before and after intravitreal bevacizumab in type 3 versus type 1 and 2 neovascularization. A prospective, case-control study.
dell'Omo R; Cassetta M; dell'Omo E; di Salvatore A; Hughes JM; Aceto F; Porcellini A; Costagliola C
Am J Ophthalmol; 2012 Jan; 153(1):155-61.e2. PubMed ID: 21861975
[TBL] [Abstract][Full Text] [Related]
5. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal VEGF levels in uveitis patients and treatment of uveitic macular oedema with intravitreal bevacizumab.
Weiss K; Steinbrugger I; Weger M; Ardjomand N; Maier R; Wegscheider BJ; Wedrich A; El-Shabrawi Y
Eye (Lond); 2009 Sep; 23(9):1812-8. PubMed ID: 19169227
[TBL] [Abstract][Full Text] [Related]
7. Comparison of intravitreal triamcinolone acetonide versus intravitreal bevacizumab as the primary treatment of clinically significant macular edema.
Liu Q; Hu Y; Yu H; Yuan L; Hu J; Atik A; Guan M; Li D; Li X; Tang S
Retina; 2015 Feb; 35(2):272-9. PubMed ID: 25105313
[TBL] [Abstract][Full Text] [Related]
8. Changes in aqueous concentrations of various cytokines after intravitreal triamcinolone versus bevacizumab for diabetic macular edema.
Sohn HJ; Han DH; Kim IT; Oh IK; Kim KH; Lee DY; Nam DH
Am J Ophthalmol; 2011 Oct; 152(4):686-94. PubMed ID: 21782151
[TBL] [Abstract][Full Text] [Related]
9. Levels of erythropoietin and vascular endothelial growth factor in surgery-required advanced neovascular glaucoma eyes before and after intravitreal injection of bevacizumab.
Zhou M; Chen S; Wang W; Huang W; Cheng B; Ding X; Zhang X
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):3874-9. PubMed ID: 23674760
[TBL] [Abstract][Full Text] [Related]
10. The variable efficacy of intravitreal bevacizumab and triamcinolone acetonide for cystoid macular edema due to radiation retinopathy.
Bakri SJ; Larson TA
Semin Ophthalmol; 2015 Jul; 30(4):276-80. PubMed ID: 24251435
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of vascular endothelial growth factor and related factors after intravitreous bevacizumab injection for retinopathy of prematurity.
Wu WC; Lien R; Liao PJ; Wang NK; Chen YP; Chao AN; Chen KJ; Chen TL; Hwang YS; Lai CC
JAMA Ophthalmol; 2015 Apr; 133(4):391-7. PubMed ID: 25569026
[TBL] [Abstract][Full Text] [Related]
12. Changes in aqueous cytokines after intravitreal triamcinolone versus bevacizumab for macular oedema in branch retinal vein occlusion.
Sohn HJ; Han DH; Lee DY; Nam DH
Acta Ophthalmol; 2014 May; 92(3):e217-24. PubMed ID: 23889803
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal bevacizumab versus combined intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration: six-month results of a randomized clinical trial.
Ahmadieh H; Taei R; Riazi-Esfahani M; Piri N; Homayouni M; Daftarian N; Yaseri M
Retina; 2011 Oct; 31(9):1819-26. PubMed ID: 21555967
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal injection of bevacizumab induces inflammatory alterations in a uveitis experimental model.
Johnsen-Soriano S; Arnal E; Sancho-Tello M; Muriach M; Almansa I; Bosch-Morell F; Navea A; Romero FJ
Eur J Ophthalmol; 2011; 21(4):427-33. PubMed ID: 21038308
[TBL] [Abstract][Full Text] [Related]
15. Comparison of intravitreal injection of bevacizumab and triamcinolone acetonide in the treatment of uveitic macular edema.
Rahimi M; Shahrzad SS; Banifatemi M
Iran J Immunol; 2012 Jun; 9(2):136-44. PubMed ID: 22735801
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes and changes in aqueous vascular endothelial growth factor levels after intravitreal bevacizumab for iris neovascularization and neovascular glaucoma: a retrospective two-dose comparative study.
Sasamoto Y; Oshima Y; Miki A; Wakabayashi T; Song D; Matsushita K; Hamasaki T; Nishida K
J Ocul Pharmacol Ther; 2012 Feb; 28(1):41-8. PubMed ID: 21992534
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal bevacizumab effects on VEGF levels in distant organs: an experimental study.
Dınc E; Yıldırım O; Necat Yılmaz S; Canacankatan N; Ayaz L; Ozcan T; Temel GO
Cutan Ocul Toxicol; 2014 Dec; 33(4):275-82. PubMed ID: 24228870
[TBL] [Abstract][Full Text] [Related]
18. Effects of intravitreal injection of tacrolimus (FK506) in experimental uveitis.
Ishikawa T; Hokama H; Katagiri Y; Goto H; Usui M
Curr Eye Res; 2005 Feb; 30(2):93-101. PubMed ID: 15814467
[TBL] [Abstract][Full Text] [Related]
19. Histological findings of uveal capillaries in rabbit eyes after multiple intravitreal injections of bevacizumab.
Sugimoto Y; Mochizuki H; Miyagi H; Kawamata S; Kiuchi Y
Curr Eye Res; 2013 Apr; 38(4):487-96. PubMed ID: 23373847
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema.
Soheilian M; Ramezani A; Obudi A; Bijanzadeh B; Salehipour M; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Peyman GA
Ophthalmology; 2009 Jun; 116(6):1142-50. PubMed ID: 19376585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
